Value through Innovation27 July 2016

Clinical Study Results

  • THOMAPYRIN S® - Migraine Disorders
    Clinical Study Number 155.8
    Study Indication Migraine Disorders
    Product THOMAPYRIN S®
    Generic Name Paracetamol + Acetylsalicylic acid
    Lab Code
    Clinical Phase III
    Study Title

    A double-blind, randomized, placebo-controlled clinical trial to confirm the rationale of the ASA + paracetamol + caffeine combination compared with ASA + paracetamol as well as ASA, paracetamol and caffeine in headache patients

    Study Document Trial synopsis 155.8 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.